lol you mean GLP studies that assess the safety of both animals with similar metabolisms as humans and in human chromosome, cardiovascular, central nervous system, invivo and invitro micronucleus genetic material which AGN just cleared last week. GLP studies come a long way to de risk in human trials . Which the first human to be dosed in the coming quarter. For a drug far superior than its first line FDA drugs that target a 4 billion dollar mark to be cleared for safety this quarter it’s worth multiples on a joke of current market cap of 16 million dollars for NYR
That’s not talking shit like yourself and trying to troll me that’s fact. Also waiting for Monday’s big trading halt and cap raise . Speak to you on Monday
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.03M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 33143 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 682527 | 2 |
View Market Depth
| Last trade - 09.16am 31/07/2025 (20 minute delay) ? |
| NYR (ASX) Chart |
Day chart unavailable